A contract worth £20M has been awarded to Balfour Beatty Kilpatrick, for a new Research and Innovation facility in Hull.
The £20M contract, which will see Balfour Beatty Kilpatrick deliver the mechanical and electrical services for a new state-of-the-art pharmaceutical research and innovation facility, has been awarded by engineering and construction company M+W Group.
Works at the facility in Hull are commencing this month, and will include the installation of a new ventilation system, small power and lighting systems, fire and intruder alarms and a building management system.
Balfour Beatty Kilpatrick will utilise its technological expertise across the project, including the latest Building Information Modelling (BIM) techniques to optimise the design, construction and performance of the building and enable future maintenance to be engineered into the scheme.
The company will also utilise its in-house modularisation capability for the bespoke design and off-site prefabrication of high-level multi-service modules, such as the roof top plant room, wiring, lighting and air handing plant.
Simon Lafferty, Balfour Beatty Kilpatrick Managing Director said: “This facility will be a flagship building and will allow us to showcase our wide range of mechanical and electrical expertise, including our design team’s knowledge of hi-tech and process sectors.
“We have collaborated with M+W Group to produce a joint BIM strategy, as well as detailed programme and commissioning plans to facilitate their needs both in the construction phase and beyond.”
The project is expected for completion next year, with Balfour Beatty employing a direct workforce of 175 at peak construction, and offering four trade apprenticeships.
If you would like to read more articles like this then please click here